Literature DB >> 16698181

Psychiatric comorbidities in a community sample of women with fibromyalgia.

Karen G Raphael1, Malvin N Janal, Sangeetha Nayak, Joseph E Schwartz, Rollin M Gallagher.   

Abstract

Prior studies of careseeking fibromyalgia (FM) patients often report that they have an elevated risk of psychiatric disorders, but biased sampling may distort true risk. The current investigation utilizes state-of-the-art diagnostic procedures for both FM and psychiatric disorders to estimate prevalence rates of FM and the comorbidity of FM and specific psychiatric disorders in a diverse community sample of women. Participants were screened by telephone for FM and MDD, by randomly selecting telephone numbers from a list of households with women in the NY/NJ metropolitan area. Eligible women were invited to complete physical examinations for FM and clinician-administered psychiatric interviews. Data were weighted to adjust for sampling procedures and population demographics. The estimated overall prevalence of FM among women in the NY/NJ metropolitan area was 3.7% (95% CI=3.2, 4.4), with higher rates among racial minorities. Although risk of current MDD was nearly 3-fold higher in community women with than without FM, the groups had similar risk of lifetime MDD. Risk of lifetime anxiety disorders, particularly obsessive compulsive disorder and post-traumatic stress disorder, was approximately 5-fold higher among women with FM. Overall, this study found a community prevalence for FM among women that replicates prior North American studies, and revealed that FM may be even more prevalent among racial minority women. These community-based data also indicate that the relationship between MDD and FM may be more complicated than previously thought, and call for an increased focus on anxiety disorders in FM.

Entities:  

Mesh:

Year:  2006        PMID: 16698181     DOI: 10.1016/j.pain.2006.04.004

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  32 in total

1.  Is psychological distress intrinsic to fibromyalgia syndrome? Cross-sectional analysis in two clinical presentations.

Authors:  Monika Salgueiro; Zigor Aira; Itsaso Buesa; Juan Bilbao; Jon Jatsu Azkue
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System.

Authors:  Emiko Petrosky; Rafael Harpaz; Katherine A Fowler; Michele K Bohm; Charles G Helmick; Keming Yuan; Carter J Betz
Journal:  Ann Intern Med       Date:  2018-09-11       Impact factor: 25.391

3.  Psychological distress and quality of life are improved in autoimmune patients through Tandem-Psychotherapy, combining individual hypnosis and eye movement desensitization and reprocessing (EMDR) treatment for trauma, followed by supportive-expressive group therapy.

Authors:  Maria Teresa Corsetti; Edoardo Rossi; Sofia Bonvino; Pietro Randazzo
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

Review 4.  [Expert testimony in post-traumatic stress disorder with pain as the main symptom].

Authors:  U T Egle; U Frommberger; B Kappis
Journal:  Schmerz       Date:  2014-08       Impact factor: 1.107

Review 5.  Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis.

Authors:  Niloofar Afari; Sandra M Ahumada; Lisa Johnson Wright; Sheeva Mostoufi; Golnaz Golnari; Veronica Reis; Jessica Gundy Cuneo
Journal:  Psychosom Med       Date:  2013-12-12       Impact factor: 4.312

Review 6.  Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome?

Authors:  Susmita Kashikar-Zuck; Christopher King; Tracy V Ting; Lesley M Arnold
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

7.  The Analgesic and Anxiolytic Effect of Souvenaid, a Novel Nutraceutical, Is Mediated by Alox15 Activity in the Prefrontal Cortex.

Authors:  Suku-Maran Shalini; Deron R Herr; Wei-Yi Ong
Journal:  Mol Neurobiol       Date:  2016-10-01       Impact factor: 5.590

8.  Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials.

Authors:  Lesley M Arnold; Daniel J Clauw; Madelaine M Wohlreich; Fujun Wang; Jonna Ahl; Paula J Gaynor; Amy S Chappell
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 9.  Comorbidity of fibromyalgia and psychiatric disorders.

Authors:  Dan Buskila; Hagit Cohen
Journal:  Curr Pain Headache Rep       Date:  2007-10

10.  Pain associated with specific anxiety and depressive disorders in a nationally representative population sample.

Authors:  Katja Beesdo; Frank Jacobi; Jürgen Hoyer; Nancy C P Low; Michael Höfler; Hans-Ulrich Wittchen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-10       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.